Wolverine Trading, LLC Cel Sci Corp Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.93 - $7.7 $20,915 - $40,979
-5,322 Reduced 29.77%
12,557 $50,000
Q4 2021

Feb 14, 2022
SELL
$7.1 - $12.82 $71,404 - $128,930
-10,057 Reduced 36.0%
17,879 $134,000
Q2 2021

Aug 06, 2021
BUY
$8.68 - $27.49 $242,484 - $767,960
27,936 New
27,936 $358,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $24.3M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email